Evidence map›Paper›PMID 34681131›Full record

ArticleBiology2021

Changes in MOTS-c Level in the Blood of Pregnant Women with Metabolic Disorders.

Małgorzata Wojciechowska, Ewa Pruszyńska-Oszmałek, Paweł A Kołodziejski, Hanna Krauss, Natalia Leciejewska, Dawid Szczepankiewicz, Jakub Bień, Marek Skrzypski, Maciej Wilczak, Maciej Sassek

Open access · goldAbstract read
In one paragraph

Article in Biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
2.6field-weighted citation impact, top 10% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Review
  8. Article
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 3 institutions in 1 country.

Małgorzata WojciechowskaDepartment of Mother and Child Health, Poznan University of Medical Sciences, ul. Polna 33, 60-535 Poznań, Poland.
Ewa Pruszyńska-OszmałekDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.ORCID 0000-0002-7182-6905
Paweł A KołodziejskiDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.ORCID 0000-0003-0715-0223
Hanna KraussDepartment of Medicine, The President Stanislaw Wojciechowski State University of Applied Sciences in Kalisz, Nowy Świat 4, 62-800 Kalisz, Poland.
Natalia LeciejewskaDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.
Dawid SzczepankiewiczDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.ORCID 0000-0002-0412-5578
Jakub BieńDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.
Marek SkrzypskiDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.ORCID 0000-0003-4059-1362
Maciej WilczakDepartment of Mother and Child Health, Poznan University of Medical Sciences, ul. Polna 33, 60-535 Poznań, Poland.
Maciej SassekDepartment of Animal Physiology, Biochemistry and Biostructure, Poznan University of Life Sciences, 60-637 Poznań, Poland.
University of Life Sciences in Poznań · PLPoznan University of Medical Sciences · PLUniwersytet Kaliski im. Prezydenta Stanisława Wojciechowskiego · PL

Funding

National Science Center 2018/31/D/NZ4/01121
6 · The paper itself

Abstract

MOTS-c peptide is a member of the group of mitochondria-derived peptides (MDP). It is a product of the open reading frame in the 12S RNA gene. Due to its features and functions in the body, this peptide is classified as a hormone. The first publications indicated that this hormone improves insulin sensitivity and lowers body weight in obese animals. This suggests that it may be an important peptide in maintaining the body's energy homeostasis. The aim of our work was to investigate the potential role of MOTS-c peptide during pregnancy, which is a condition prone to metabolic disorders. The research covered healthy, obese women and women with thyroid disorders. The obtained results indicated an increase in the concentration of MOTS-c in the blood of mothers and newborns in the obese group as compared to the healthy control group and a corresponding decrease in the concentration of this peptide in mothers and newborns in the group with hypothyroidism compared to the obese group. Moreover, we also observed a strong positive correlation between the concentration of MOTS-c in maternal blood and in umbilical cord blood. In summary, the MOTS-c peptide shows changes in blood concentration in various physiological states and may, in the future, become an important tool in the fight against metabolic diseases such as obesity or type 2 diabetes.

Indexed as

mothers’ bloodMOTS-cobesityumbilical cord blood

Identifiers

PMID34681131
PMCPMC8533113
OpenAlexW3207132511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.